Johnson Pharmacare Share Price
Small Cap | Service | BSE: 532154
₹ 
-- (-- %)
Last Updated:
BEARISH
Overview
Open (₹) --
High (₹) --
Low (₹) --
Prev. Close (₹) --
Volume --
VWAP (₹) N/A
ROCE (%) -0.33
Industry P/E 53.82
TTM P/E --
P/B Ratio 0.96
Market Cap (₹) Cr.54.45
Dividend Yield (%)--
EPS (₹) 0.00
ROE0.00%
Sales Growth (%) --
Profit Growth (%)-84.81
Day Range
52 Week Range
0.681.44
SWOT Analysis
- Bullish MACD crossover (12,6,9) indicates potential upward price movement.
- Positive ROC (9) indicates upward momentum.
- Strong trend indicated by ADX above 25.
Technicals
Technical Rating
BEARISHRSI N/A
MFI N/A
ATR N/A
Commodity Channel Index N/A
ROC125 N/A
ROC21 N/A
Williams %R N/A
EMA & SMA
Current Price
Bullish Moving Averages
0
Bearish Moving Averages
0
5 Day N/A
9 Day N/A
10 Day N/A
12 Day N/A
14 Day N/A
20 Day N/A
26 Day N/A
50 Day N/A
100 Day N/A
200 Day N/A
Deals & Announcements
Bulk and Block Deals
Insider Trading
Corporate Actions
| Announcement Date | Subject | Ex - Date | Record Date |
|---|---|---|---|
| 18 Feb, 2022 | Bonus issue of equity shares in the ratio of 1:10 of Re. 1/-. | 07 Apr, 2022 | 08 Apr, 2022 |
| 14 Oct, 2021 | Stock split from Rs. 10/- to Re. 1/-. | 05 Jan, 2022 | 06 Jan, 2022 |
Announcements
| Date | Source | Detail |
|---|---|---|
| 31 Jan, 2025 | BSE India | PFA |
| 31 Jan, 2025 | BSE India | PFA |
| 31 Jan, 2025 | BSE India | Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of the SEBI (Listing Obligations and\r\nDisclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of the\r\nCompany, in their meeting held on today i.e. Friday 31st January 2025 at the Registered Office of the\r\nCompany and transacted the following major businesses:\r\n1.) Considered and approved Un-audited financial results for the quarter and nine months ended on 31st\r\nDecember 2024.\r\nThe board meeting commented at 06:25 PM and concluded at 06:45 PM\r\nPlease take the above intimation in your records.\r\nThanking You, |
| 22 Jan, 2025 | BSE India | PFA |
| 21 Jan, 2025 | BSE India | Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/01/2025 ,inter alia, to consider and approve Pursuant to Regulation 29 of the SEBI (Listing Obligations and Disclosure Requirements ) Regul ations, 2015,\r\nwe would like to inform you t hat a meeting of the Board of Directors of the Company will be held on\r\nFriday 31st January 2025 inter alia, to consider following business. -\r\n1.) To approve and take on record the Un-Audited Financial Results of the Company for the quarter ended\r\non 31st December 2024\r\n2.) Any other matter with the permission of the board which the Board may think fit.\r\nPlease take the above intimation in your records.\r\nThanking You. |
| 13 Nov, 2024 | BSE India | PFA |
| 13 Nov, 2024 | BSE India | Pursuant to Second proviso to Regulation 30(6) and Regulation 33 of t he SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 we hereby inform you that the Board of Directors of the Company, in their meeting held on today i.e. Wednesday 13th November 2024 at the Registered Office of the Company and transacted the following major businesses:\r\n\r\n1.) Considered and approved Un-audited financial results for the quarter ended as on 30th September,\r\n2024.\r\n\r\nThe meeting commenced at 06:15 P.M. and concluded at 06.40P.M.\r\n\r\nKindly take the same on your record and oblige.\r\n\r\nThanking You.\r\n\r\n\r\n |
| 23 Oct, 2024 | BSE India | PFA |
| 15 Oct, 2024 | BSE India | Johnson Pharmacare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/11/2024 ,inter alia, to consider and approve PFA |
| 07 Oct, 2024 | BSE India | pfa |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results | -- | 22 Jan, 2025 | 31 Jan, 2025 |
| Quarterly Results | -- | 16 Oct, 2024 | 13 Nov, 2024 |
| Quarterly Results | -- | 26 Jul, 2024 | 01 Aug, 2024 |
| Audited Results | -- | 20 May, 2024 | 25 May, 2024 |
| Quarterly Results | -- | 17 Jan, 2024 | 22 Jan, 2024 |
| Quarterly Results | -- | 27 Oct, 2023 | 01 Nov, 2023 |
| Quarterly Results | -- | 07 Aug, 2023 | 10 Aug, 2023 |
| Audited Results | -- | 19 May, 2023 | 24 May, 2023 |
| Quarterly Results | -- | 30 Jan, 2023 | 02 Feb, 2023 |
| Quarterly Results | -- | 04 Nov, 2022 | 09 Nov, 2022 |
Share Holding Pattern
| Owner Name | Dec, 2024 | Sept, 2024 | Jun, 2024 | Mar, 2024 | Dec, 2023 |
|---|
About Johnson Pharmacare
Johnson Pharmacare is a Public Limited Listed company incorporated on 30/06/1994 and has its registered office in the State of Gujarat, India. Company’s Corporate Identification Number(CIN) is L51100GJ1994PLC022388 and registration number is 022388. Currently company belongs to the Industry of Services - Others. Company’s Total Operating Revenue is Rs. 0.00 Cr. and Equity Capital is Rs. 55.00 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1994
Managing Director
-- --
NSE Symbol
--
Johnson Pharmacare Management
| Name | Designation |
|---|---|
| Mr. Ramanlal Trivedi | WholeTime Director & CFO |
| Mr. Pareshbhai Ganpatbhai Sengal | Director |
| Mr. Manisha Patel Maneklal | Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| CRISIL | ₹40,850.67 | ₹5,349.20  ₹5,109.15(4.70%) | ₹3,665.100 - ₹5,921.100 |
| CDSL | ₹37,150.80 | ₹1,239.90  ₹1,297.60(-4.45%) | ₹811.000 - ₹1,989.800 |
| Inter.Gemmo | ₹25,350.49 | ₹457.15 ₹480.80(-4.92%) | ₹454.550 - ₹610.400 |
| Indegene | ₹14,403.99 | ₹590.30 ₹618.70(-4.59%) | ₹468.900 - ₹736.600 |
| Quess Corp | ₹9,815.59 | ₹609.80 ₹627.85(-2.87%) | ₹460.000 - ₹875.000 |
FAQs on Johnson Pharmacare
What is the share price of Johnson Pharmacare?
The share price of Johnson Pharmacare on NaN undefined, NaN is ₹ .
What is 52W high and 52W low share price of Johnson Pharmacare?
The highest and lowest 52W share prices of Johnson Pharmacare are ₹ 1.440 and ₹ 0.680
What is the market cap of Johnson Pharmacare?
The market capitalization of Johnson Pharmacare as of NaN undefined, NaN is ₹ 54.45 Crores
What is the P/E ratio of Johnson Pharmacare?
The current P/E ratio of Johnson Pharmacare as of NaN undefined, NaN is 53.82
What is the PB ratio of Johnson Pharmacare?
The PB ratio of Johnson Pharmacare as of NaN undefined, NaN is 0.96
Top Gainers
948IHFL26I
IBHFL NCD186
₹845
₹705 (0.2%)
GREAVESCOT
Greaves
₹281.85
₹234.9 (0.2%)
ASHSI
Ashirwd Stl
₹45.66
₹38.05 (0.2%)
CAPRO
Caprola.Chem
₹62.4
₹52 (0.2%)
Top Losers
DHANBANK
Dhanalak.Bnk
₹32.19
₹35.97 (-0.11%)
08MPD
08MPD
₹8.66
₹9.62 (-0.1%)
BALTE
BalurghtTran
₹27.13
₹31.24 (-0.13%)
DARSHANORNA
Darshan Orna
₹4.57
₹5.07 (-0.1%)
Market Indices
Sensex
₹78,699.07
₹78,472.48 (0%)